期刊文献+

氟康唑治疗慢性阻塞性肺疾病继发呼吸道真菌感染三种给药方法的成本效果分析 被引量:2

Cost-effectiveness analysis of three methods of fluconazole for chronic obstructive pulmonary disease complicated with fungus infection in hospital
原文传递
导出
摘要 目的探讨治疗慢性阻塞性肺疾病(COPD)继发呼吸道真菌感染的合理用药方法。方法选择60例COPD继发呼吸道感染患者分为三组A组氟康唑02静滴,qd×10d;B组氟康唑02静滴,qd×3d,后改为015口服,qd×7d;C组氟康唑015口服,qd×10d。运用经济学的成本效果方法进行分析评价。结果三种不同给药方法的成本效果比分别为5538、2783、1602。结论口服氟康唑为治疗COPD继发呼吸道真菌感染的最佳方法。 Objective To provide a rational arrangement for chronic obstructive pulmonary disease(COPD) complicated with fungus infection with our limited cost.Methods 60 cases of COPD complicated with fungus infection in hospital were selected:A group(fluconazole,200mg,ivdrip,qd×7d);B group(fluconazole,200mg ivdrip qd×3d,then 150mg po,qd×7d);C group:fluconazole,150mg po,qd×10d).The plans were evaluated by pharmacoeconomic cost-effectiveness analysis.Result The cost-effectiveness ratio of three methods was 55.38,27.83,16.02,respectively.Conclusion Methods C is the best one.
出处 《中国基层医药》 CAS 2005年第2期191-193,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 治疗 氟康唑 继发 呼吸道真菌感染 口服 给药方法 慢性阻塞性肺疾病 比分 结论 目的 Chronic obstructive pulmonary disease Fungus Fluconazole Cost-effectiveness analysis
  • 相关文献

参考文献4

二级参考文献8

共引文献1909

同被引文献29

  • 1陈小东.老年慢性阻塞性肺疾病的药物治疗[J].世界临床药物,2004,25(9):536-539. 被引量:2
  • 2丁艳华,于振香,姜洪宇,李杰,付军.氟康唑治疗老年念珠菌感染的疗效及安全性[J].中国老年学杂志,2005,25(12):1549-1550. 被引量:4
  • 3冉丕鑫,王辰,姚婉贞,陈萍,康健,黄绍光,陈宝元,王长征,倪殿涛,周玉民,刘升明,王小平,王大礼,吕嘉春,郑劲平,钟南山.我国部分农村地区40岁以上女性慢性阻塞性肺疾病危险因素分析[J].中华内科杂志,2006,45(12):974-979. 被引量:51
  • 4何权瀛.中国慢性阻塞性肺疾病患者现状研究主要结果.中国医学论坛报,2007,9(33):5-5.
  • 5陈洁,张钧,张丹,等.药物经济学[M].成都:成都科技大学出版社,2010:220.
  • 6Denning DW,Munoz P.Advances in invasive fungal infection and antifungal therapy:Introduction[J].Clin Microbiol Infect,2001,7(Suppl 2):Ⅵ.
  • 7Pfaller MA,Diekema DJ,Messer SA,et al.Activities of fluconazole and voriconazole against 1586 recent clinical isolates of Candida species determined by broth microdilution,disk diffusion,and E test methods:Report from the ARTEMIS global antifungal susceptibility program,2001[J].J Clin Microbiol.2003,41(4):1440-1446.
  • 8Beeh KM,Wiew rodt R,Salem AE,et al.Efficacy and safety of salmeterol in long-term therapy in patients with chronic obstructive airway diseases[J].Pneumologie,2000,54(6):225-31.
  • 9Global initiative for chronic obstructive lung disease,pocket guide to COPD diagnosis,management,and prevention, revised 2013.
  • 10Fenton C,Keating GM.Inhaled salmeterol/flutieasone propionate: a review of its use in chronic obstructive pulmonary disease[J].Drugs, 2004,64(17): 1975-1996.

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部